| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Aditya Birla SL Nifty Healthcare ETF (G) |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.02 |
| Equity |
99.98 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
50.46% |
| Top 10 Holdings |
77.19% |
| Top 25 Holdings |
100.00% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
78.13 |
| Healthcare |
21.85 |
| Cash |
0.02 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
4.98 |
| PE Ratio |
37.48 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
18.36 |
| DIVI LABORATORIES LTD. |
8.13 |
| Max Healthcare Institute Limited |
8.11 |
| Apollo Hospitals Enterprise Limited |
8.04 |
| Dr Reddys Laboratories Limited |
7.82 |
| Cipla Limited |
7.57 |
| Lupin Limited |
5.57 |
| Fortis Health Care Ltd |
4.90 |
| Torrent Pharmaceuticals Limited |
4.52 |
| Laurus Labs Limited |
4.17 |
| Aurobindo Pharma Limited |
3.41 |
| Alkem Laboratories Limited |
3.29 |
| Glenmark Pharmaceuticals Limited |
3.21 |
| Biocon Limited |
2.78 |
| Mankind Pharma Limited |
2.54 |
| Zydus Lifesciences Limited |
2.30 |
| IPCA Laboratories Limited |
2.12 |
| Abbott India Limited |
1.38 |
| Piramal Pharma Limited |
0.96 |
| Syngene International Limited |
0.80 |
| Net Receivables / (Payables) |
0.02 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
